Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV treatment has greatly improved over the past 36 years.
The novel attachment inhibitor led to viral suppression in 60% of people with extensive prior treatment.
CytoDyn’s monoclonal antibody PRO 140 injected once a week suppressed HIV in some people living with the virus for well over a year.
Here’s a timeline of the highlights.
Celebrating 20 years of effective HIV treatment
A new entry inhibitor (EI) is in the works.
Long-awaited results from a Phase II study of ibalizumab, an antibody-based therapy in early stage development for several years
Tobira Therapeutics is recruiting for a Phase IIb study of its CCR5/CCR2 entry inhibitor cenicriviroc (TBR-652). It is hoped that cenicriviroc...
People taking older anti-seizure medications that are broken down by the same liver enzyme (CYP3A4) as many common antiretroviral (ARV) drugs...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.